CNN1
Calponin-1
Also known as: CNN1_HUMAN, Sm-Calp, SMCC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51911
- Gene
- CNN1
- Ensembl
- ENSG00000130176
- Chromosome
- 19
- Canonical length
- 297 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Actin filaments
OverviewNCBI Gene
Predicted to enable actin filament binding activity. Involved in negative regulation of vascular associated smooth muscle cell proliferation. Located in cytoskeleton. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>P51911|CNN1
1 MSSAHFNRGP AYGLSAEVKN KLAQKYDHQR EQELREWIEG VTGRRIGNNF MDGLKDGIIL
61 CEFINKLQPG SVKKINESTQ NWHQLENIGN FIKAITKYGV KPHDIFEAND LFENTNHTQV
121 QSTLLALASM AKTKGNKVNV GVKYAEKQER KFEPGKLREG RNIIGLQMGT NKFASQQGMT
181 AYGTRRHLYD PKLGTDQPLD QATISLQMGT NKGASQAGMT APGTKRQIFE PGLGMEHCDT
241 LNVSLQMGSN KGASQRGMTV YGLPRQVYDP KYCLTPEYPE LGEPAHNHHA HNYYNSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CNN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 2,743 nTPM
Expression across tissuesHPA
Tissue
- colon: 2,743 nTPM
- blood vessel: 2,087 nTPM
- smooth muscle: 2,059 nTPM
- endometrium: 1,691 nTPM
- urinary bladder: 1,626 nTPM
- seminal vesicle: 1,493 nTPM
Single-cell type
- smooth muscle cells: 2,791 nCPM
- breast myoepithelial cells: 837 nCPM
- late spermatids: 741 nCPM
- vascular smooth muscle cells: 526 nCPM
- decidual stromal cells: 451 nCPM
- early spermatids: 450 nCPM
Immune cell
- total PBMC: 1.4 nTPM
- myeloid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 9.8 nTPM
- hypothalamus: 7 nTPM
- basal ganglia: 6.6 nTPM
- choroid plexus: 4.8 nTPM
- midbrain: 3.5 nTPM
- hippocampal formation: 3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 1.21
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- actomyosin structure organization
- negative regulation of vascular associated smooth muscle cell proliferation
- regulation of smooth muscle contraction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CNN1 as an antibody target. Whether an autoantibody or antibody against CNN1 could matter depends on whether native CNN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CNN1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CNN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...